View Full Company Profile

agilon health, inc.

CIK: 1831097 Filed: March 30, 2026 8-K Financial Distress High Impact

Key Highlights

  • Completed a 1-for-25 reverse stock split to maintain NYSE listing compliance.
  • Successfully avoided potential delisting by raising the share price above the $1.00 threshold.
  • Maintains a significant market presence, supporting over 2,500 primary care physicians.
  • Preserved institutional investor eligibility by keeping the stock price within tradable ranges for ETFs and mutual funds.

Event Analysis

agilon health, inc. Material Event: Understanding the Reverse Stock Split

Here is the latest news on agilon health. This guide helps you understand the recent changes without the legal paperwork.


1. What happened?

Agilon health completed a 1-for-25 reverse stock split. This reduced the total number of shares from about 415 million to roughly 16.6 million. While the share count dropped by 96%, your percentage of ownership in the company stays the same. This move consolidates shares, which mathematically increases the price of each share by 25 times.

2. When did it happen?

The company filed the legal paperwork in Delaware on March 30, 2025. The split took effect at 5:00 p.m. Eastern Time that day. The stock began trading on the New York Stock Exchange (NYSE) at the new, split-adjusted price when the market opened on March 31, 2025.

3. Why did it happen?

The company needed to meet NYSE listing rules, which require a minimum average closing price of $1.00 per share over 30 trading days. Agilon’s stock price fell throughout 2024 and early 2025 due to rising medical costs and lowered earnings expectations. By raising the share price, the company avoids being delisted, which keeps the stock available for institutional investors and maintains liquidity.

4. Why does this matter?

A reverse stock split is purely cosmetic. It does not change the company’s financial health, such as its $4.5 billion annual revenue or its ongoing challenges with medical profit margins. However, it shows that management is concerned about the stock’s recent performance. This is a defensive move to keep the stock eligible for mutual funds and ETFs, which often cannot hold stocks trading below $1.00 or $5.00.

5. Who is affected?

  • Investors: You do not need to take action. Brokerage accounts updated share counts automatically on March 31. If you held fewer than 25 shares, or a number not divisible by 25, you will receive cash for your fractional shares.
  • The Company: Agilon successfully reset its share price to satisfy NYSE rules. This preserves its ability to raise money in public markets if necessary.
  • Patients and Doctors: This is a corporate financial move. It does not change the daily operations of the agilon platform, which supports over 2,500 primary care physicians and serves many Medicare Advantage patients.

6. What should investors know?

  • Don't be fooled by the price jump: If the stock price appears to be up 2,400%, do not mistake this for growth or good news. It is simply the mechanical result of the 25-to-1 consolidation.
  • Focus on the business: A reverse split is a symptom of a low stock price. Focus on the company's "medical margin" and how it manages the costs that caused the stock to drop.
  • Check your account: Your brokerage app might show a temporary "loss" or "gain" while it updates your share count. Because your cost basis per share also increased by 25 times, your total investment value remains the same.

7. How to evaluate your next move

When deciding whether to hold or sell, look past the stock split and focus on the fundamentals:

  • Medical Margins: Are they successfully controlling the costs of care for their patients?
  • Profitability: Is the company moving toward consistent earnings, or are they still burning cash?
  • Market Position: Does their model for supporting primary care physicians still have a competitive advantage in the Medicare Advantage space?

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.

Key Takeaways

  • The price jump is purely mechanical and does not reflect underlying business growth.
  • Investors should focus on medical margins and cost management rather than the split-adjusted price.
  • Brokerage accounts will update automatically; fractional shares are settled in cash.
  • The move is a defensive measure to ensure continued access to public capital markets.

Why This Matters

Stockadora surfaced this event because a reverse stock split is a critical 'red flag' signal that often indicates underlying financial strain. While the split itself is a mechanical accounting change, it highlights the company's struggle to maintain NYSE listing standards amidst rising medical costs.

This event is a turning point for shareholders: it marks the transition from a growth-focused narrative to a defensive phase. We highlighted this to ensure you distinguish between artificial price appreciation and the actual operational health of the business, which remains the primary driver of long-term value.

Financial Impact

The reverse split consolidated 415 million shares into 16.6 million, mathematically increasing the share price by 25x without changing total market cap.

Affected Stakeholders

Investors
Institutional Investors
Primary Care Physicians

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Event Date: March 30, 2025
Processed: March 31, 2026 at 09:19 AM

AI-Generated Analysis

This analysis is AI-generated from SEC filings. This is educational content, not financial advice. Always consult a financial advisor before making investment decisions.

Back to All Events